To delineate the mechanism by which USP45 stabilizes MRGPRF in melanoma cells, we treated A375 and SK‐MEL‐2 cells with protein synthesis inhibitor CHX and proteasome inhibitor MG132. Here, MRGPRF is linked to melanoma.